Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | MGLL | Q99685 | 2/20 | 0.53 |
| ▸ | FAAH | O00519 | 1/20 | 0.53 |
| ▸ | RPA1 | P27694 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | KCNJ6 | P48051 | 6/20 | 0.45 |
| ▸ | KCNJ3 | P48549 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | KCNJ5 | P48544 | 2/20 | 0.43 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.43 |
| ▸ | USP8 | P40818 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2598511 | 0.81 | L3MBTL1 (0.51) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL15781026 | 0.80 | CACNA1B (0.67) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL13157595 | 0.80 | MGLL (0.51) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL31522194 | 0.79 | NPC1 (0.59) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL6053457 | 0.78 | RAB9A (0.67) | NPC1RAB9ALMNASMN1; SMN2RPA1 | |
| SCHEMBL1011586 | 0.78 | RAB9A (0.88) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL11790285 | 0.78 | DDB1 (0.48) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL3093919 | 0.78 | KCNJ6 (0.50) | NPC1RAB9ALMNATP53PKM | |
| SCHEMBL12185564 | 0.77 | PRCP (0.47) | SMN1; SMN2MGLLKCNJ6KCNJ3KCNJ5 | |
| SCHEMBL12186018 | 0.77 | CACNA1B (0.49) | NPC1RAB9ALMNATP53PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106831584-B | A kind of efficient method for preparing tri- substituted pyrazolecarboxylic class compound of 1,3,5- | 江西师范大学 | 2019-11-22 | — | — | CN | claimed |
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | BAYER AG (DE) | 2026-01-08 | — | — | US | disclosed |
| EP-4555128-A1 | ELECTROCHEMICAL SYNTHESIS OF PYRAZOLINES AND PYRAZOLES | Bayer Aktiengesellschaft (DE) | 2025-05-21 | — | — | EP | disclosed |
| CN-119698496-A | Electrochemical synthesis of pyrazolines and pyrazoles | 拜耳公司 | 2025-03-25 | — | — | CN | disclosed |
| WO-2024012791-A1 | ELECTROCHEMICAL SYNTHESIS OF PYRAZOLINES AND PYRAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260009142-A1 | Electrochemical synthesis of pyrazolines and pyrazoles | CYP2E1, CYP2F1, CYP4F2 | NPC1 4503/4885RAB9A 4644/4885LMNA 3391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.